#United States #New York #Gross Law Firm #Alto Neuroscience #ANRO

Notice for Shareholders of Alto Neuroscience, Inc.

Important Information for Shareholders

Shareholders of Alto Neuroscience, Inc. (NYSE: ANRO) are urged to reach out to The Gross Law Firm as per the notice issued on August 21, 2025. This advisory is particularly crucial for those who acquired shares during a specified class period. The law firm seeks to ensure that investors are aware of their rights and the steps they need to take regarding a potential class action.

Class Period Details

The lawsuit encompasses all individuals and entities who purchased or acquired Alto common stock in connection with the Offering Documents issued during the Company’s initial public offering around February 2, 2024. Additionally, it includes those who purchased the company’s securities between February 2, 2024, and October 22, 2024. This comprehensive class action serves to represent shareholders who might have suffered losses during this timeframe due to allegedly misleading statements made by the company.

Allegations Against Alto Neuroscience

The legal complaint reveals serious allegations against Alto Neuroscience. It is claimed that during the defined class period, the defendants made baseless assertions regarding the effectiveness of their product pipeline, particularly a treatment known as ALTO-100. Allegedly, the company misrepresented the efficacy of ALTO-100 in treating major depressive disorder. Consequently, assertions about ALTO-100's clinical, regulatory, and commercial prospects have been deemed exaggerated, suggesting that the financial forecast of Alto Neuroscience was unwarranted. This misrepresentation has led to public statements that were materially false and misleading, prompting the need for shareholder action.

Registration and Next Steps

Shareholders interested in this class action should act swiftly, as the deadline for registration to potentially be appointed as lead plaintiff is September 19, 2025. It is important to emphasize that registering does not obligate anyone to become a lead plaintiff but is a step towards participating in possible recovery relating to their losses. Once registered, shareholders will gain access to a portfolio monitoring system, providing them with updates about the ongoing case.

No Cost to Participate

Importantly, there is no associated cost for shareholders who decide to join this class action. Participation does not incur any obligation, and shareholders are encouraged to secure their rights proactively by reaching out to The Gross Law Firm. They emphasize their commitment to advocating for investors who have been impacted by fraudulent or deceptive business practices.

About The Gross Law Firm

The Gross Law Firm has a well-established reputation nationally for representing class action cases. Their mission is to safeguard the rights of investors who suffer due to deceitful actions and to hold companies accountable for their obligations to shareholders. Their approach stresses responsible business practices and corporate responsibility.

For further details or to register your claim, please visit the Gross Law Firm’s website.